Inhibition of [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding by the excitotoxin beta-N-oxalyl-L-alpha,beta-diaminopropionic acid.
D000599:Amino Acids, Diamino / Q000494:pharmacology*; D000818:Animals; D001921:Brain; D007051:Ibotenic Acid / Q000031:analogs & derivatives / Q000493:pharmacokinetics*; D066298:In Vitro Techniques; D010069:Oxadiazoles; D010080:Oxazoles / Q000493:pharmacokinetics*; D051381:Rats; D011919:Rats, Inbred Strains; D018091:Receptors, AMPA; D011955:Receptors, Drug / Q000187:drug effects / Q000378:metabolism; D018092:Kainic Acid Receptors; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter / Q000187:drug effects* / Q000378:metabolism; D013570:Synaptic Membranes / Q000187:drug effects / Q000378:metabolism; D014118:Toxins, Biological / Q000494:pharmacology; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
D000599:Amino Acids, Diamino; D007051:Ibotenic Acid; D010069:Oxadiazoles; D010080:Oxazoles; D018091:Receptors, AMPA; D011955:Receptors, Drug; D018092:Kainic Acid Receptors; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D014118:Toxins, Biological; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; C100126:oxalyldiaminopropionic acid